Ifp Advisors, Inc Adamis Pharmaceuticals Corp Transaction History

Ifp Advisors, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$0.92 - $1.18 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$0.66 - $1.23 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$0.54 - $1.79 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$0.4 - $1.01 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$0.52 - $1.45 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$0.33 - $0.66 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$0.33 - $0.89 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	SELL	$0.51 - $1.26 $748 - $1,849	-1,468 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$0.7 - $1.46 $1,027 - $2,143	1,468 New	1,468 $1,000
Q1 2019 May 15, 2019	SELL	$2.02 - $3.22 $2,965 - $4,726	-1,468 Closed	0 $0
Q4 2017 Jan 24, 2018	SELL	$3.5 - $5.65 $350 - $565	-100 Reduced 6.38%	1,468 $0
Q3 2017 Oct 30, 2017	SELL	$4.5 - $5.65 $147,892 - $185,687	-32,865 Reduced 95.45%	1,568 $8,000
Q2 2017 Jun 03, 2019	BUY	N/A	32,965 Added 2245.57%	34,433 $179,000
Q2 2016 Jun 03, 2019	BUY	N/A	1,468	1,468 $4,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.